One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-150519
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 44 |
Affiliation: McGill University Health Centre, Institute of Cancer Research, University of Calgary, Pfizer (United States), Princess Margaret Cancer Centre, University of Chicago, UC San Diego Health System, Vanderbilt University, BMT Group (United States), Duke University Hospital, University of Iowa, Texas Oncology, Baylor Scott & White Health, Ochsner Health System, Massachusetts General Hospital, Memorial Sloan Kettering Cancer CenterElranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) Targeted CD3-Engaging Bispecific Molecule, for Patients with Relapsed or Refractory Multiple Myeloma: Results from Magnetismm-1
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
